Saturday, 31 October 2026European Markets

OENEO And SAINT JEAN GROUPE Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - oeneo (sbt.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
oeneo (sbt.pa) €14.15 2.19% 12.08%
saint jean groupe (sabe.pa) €19.10 0.53% 0.81%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. oeneo (sbt.pa)

2.19% forward dividend yield and 12.08% return on equity

oeneo sa operates in the wine industry worldwide. the company manufactures and sale of cork closures. it also provides solutions in wine making and spirits. oeneo sa is headquartered in bordeaux, france. oeneo sa is a subsidiary of caspar sas.

earnings per share

as for profitability, oeneo has a trailing twelve months eps of €0.63.

pe ratio

oeneo has a trailing twelve months price to earnings ratio of 22.46. meaning, the purchaser of the share is investing €22.46 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.08%.

moving average

oeneo's value is above its 50-day moving average of €14.13 and under its 200-day moving average of €14.30.

revenue growth

year-on-year quarterly revenue growth grew by 4.6%, now sitting on 348.24m for the twelve trailing months.

more news about oeneo.

2. saint jean groupe (sabe.pa)

0.53% forward dividend yield and 0.81% return on equity

saint jean groupe société anonyme, through its subsidiaries, operates in the agri-food sector in france. the company offers ravioles, dumplings, fresh pasta, and delicatessen products under the saint, royans, ravioles de romans, quenelles la royale, and comptoir du pastier brand names. the company is headquartered in dardilly, france.

earnings per share

as for profitability, saint jean groupe has a trailing twelve months eps of €0.18.

pe ratio

saint jean groupe has a trailing twelve months price to earnings ratio of 106.11. meaning, the purchaser of the share is investing €106.11 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.81%.

more news about saint jean groupe.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com